Bristol-Myers Squibb (BMY) to Take $1.8B Non-Cash Charge on Hep C Development Halt
Tweet Send to a Friend
On August 23, 2012 Bristol-Myers Squibb Company (NYSE: BMY) issued a press release announcing that it has discontinued development of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
